[300 Pages Report] Rising from US$ 2.5 Billion in 2022 to US$ 7.8 Billion by 2032, the global clostridium diagnostics market is projected to exhibit a CAGR of 12.2% during the forecast period. From 2015-2021, the market displayed a CAGR of 13.6%. The growth of the market can be attributed to the rising prevalence of clostridium-related diseases and the increasing campaigns to educate individuals regarding the condition.
| Report Attribute | Key Statistics |
|---|---|
| Clostridium Diagnostics Market Size (2022) | US$ 2.5 Billion |
| Clostridium Diagnostics Market Revenue Forecast (2032) | US$ 7.8 Billion |
| Clostridium Diagnostics Market Growth Rate (2022-2032) | 12.2% |
As per the Centres for Disease Control and Prevention, Clostridium perfringens bacteria are one of the most common causes of foodborne illness (food poisoning). CDC estimates that these bacteria cause about 1 million illnesses in the States every year.
Such a significant number is expected to boost demand for an efficient clostridium diagnostics method. Other factors responsible for the market growth include changing lifestyles, developing healthcare infrastructure, and technological development such as AI and automation.
The high fatality rate of clostridium diseases, growing demand for animal-based products, and growing usage of animals in agriculture are expected to benefit the industry in the forecast period. As per the United States Department of Agriculture (USDA), the population of cattle in the U.S in 2016, was 92 million and a significant population was susceptible to clostridium conditions. Such factors are likely to benefit the market in the forecast period.
The growing focus of players to offer vaccines for the fatal situation is predicted to augment the market size in the forecast period. For instance, in February 2019, Merck Animal Health and Rapid Genomics signed an agreement for vaccine verification, where Merck has exclusive rights to Rapid Genomics’ vaccination verification tool, Viral Flex-Seq.
Key companies in the market are taking several initiatives to conduct clinical trials for the development of the clostridium vaccine. For instance, in January 2017, Pfizer announced a phase II study of investigational Clostridium difficile vaccine candidate: PF-06425090; for the prevention of C. difficile infection.
The randomized Phase II study was conducted to examine the safety, immunogenicity, and tolerability of the vaccine in healthy adults 65 to 85 years of age. Pfizer initiated a phase III study in March 2017, with 16,000 participants. Attributed to such factors, the market is projected to flourish in the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Ongoing Partnerships among Players and Launch of new Vaccines to Spike the Market Growth Graph Notably
Growing expenditure on healthcare infrastructure is expected to have played a significant role in developing the market during the timeframe. As per the analysis, from 2015-2021, the market is projected to display a CAGR of 13.6%. Initiatives by players in the market are expected to have strengthened the industry growth during the aforementioned time period.
For instance, in August 2016, Boehringer Ingelheim Vetmedica, Inc. launched the Alpha-7 vaccine, the only first-of-a-kind vaccine, single-dose vaccination offering a 7-way defense against clostridium diseases.
Other factors contributing to the market growth include technological development in diagnostic equipment and growing awareness about clostridium-related disorders. Owing to the aforementioned factors, the market is anticipated to have developed significantly during the time period from 2015-2021.
During the forecast period from 2022-2032, the market is expected to display a CAGR of 12.2%. The growth of the market can be attributed to the growing focus of players to expand their footprint in the industry. For instance, in March 2021, Peggy Lillis Foundation for Clostridium difficile infections announced a partnership with Ferring Pharmaceutical through a new sponsorship to assist new and existing patient advocacy initiatives.
The sponsorship focuses on supporting the organization’s National C. doff Adovacy summit, 2021 FIGHT C.Diff Gala. Attributed to such factors, the global clostridium diagnostics market is projected to develop significantly during the forecast period from 2022-2032.
Growing Launch of New Vaccines for Clostridium Condition to Boost the Market
Players in the market are taking various efforts to offer effective vaccines against the deadly Clostridium condition, which is expected to benefit the industry in the forecast period. Growing cases of the condition among animals have encouraged players in the market to launch new vaccines.
For instance, in August 2021, Huvepharma Canada Corportation Inc. launched a new vaccine that has been shown to be effective against necrotic enteritis (NE) due to Clostridium perfringens Type A in broiler chickens.
Other factors contributing to the market growth include increasing awareness about the condition, changing lifestyles, and the development of healthcare infrastructure, among others. Such factors are expected to drive the global clostridium diagnostics market during the forecast period.
Principal Consultant
Lack of Awareness and Resources in Developing Countries to Hamper the Market Growth
Scarcity of resources and lack of awareness in developing countries is expected to be the most significant factor impeding market growth during the forecast period. Further, the high costs involved in R&D and vaccine manufacturing is projected to be another potential challenge to the market in the forecast period.
Launch of Awareness Campaigns in the States to Augment the Market Size of the U.S
As per the analysis, the U.S is anticipated to secure a market value worth US$ 2.7 Billion during the forecast period. From 2022-2032, the country is projected to display a CAGR of 11.8%, while it was 13.3% from 2015-2021.
The growth of the U.S market can be attributed to the growing awareness among people owing to the rising launch of campaigns by various bodies. For instance, the “See C. diff” campaign, launched by Peggy Lillis Foundation in December 2020, attained its objective by reaching more than 250,000 Americans.
The organization launched the “See C. diff” to commemorate C.diff Awareness Month in 2019, and reached about 80,000 people. Attributed to such efforts, the market in the U.S is projected to flourish significantly in the coming time.
Implementation of Favorable Initiatives to Support the Market in Japan
As per the analysis, the market in Japan is projected to display a CAGR of 11.1% during the forecast period from 2022-2032. The market value is estimated at US$ 464 Million by 2032. From 2015-2021, the country experienced a CAGR of 12.4%.
The growth of the Japanese market can be attributed to the implementation of favorable initiatives. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases.
SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Due to such factors, the market in Japan is expected to experience various opportunities for expansion in the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Growing Adoption of Antibiotics for the Treatment of Infection to Develop the Segmental Growth
As per the analysis, by technology, the global clostridium diagnostics market is expected to be dominated by the immunoassays segment. The segment is anticipated to display a CAGR of 11.7% during the assessment period from 2022-2032.
The development of the segment can be attributed to the increasing adoption of antibiotics for infection treatment. Also, development in drug design and availability of higher antibiotics, and growing awareness about the disease are projected to strengthen the segmental growth in the forecast period.
Growing Prevalence of Clostridium-related Ailments to Boost the Segmental Growth
According to the analysis, the clostridium difficile segment is anticipated to dominate the global clostridium diagnostics market during the forecast period. From 2022-2032, the segment is projected to display a CAGR of 11.6%.
The development of the segment can be attributed to the growing prevalence of clostridium-related diseases and expanding geriatric population. Also, developing healthcare infrastructure and technical development are projected to be other salient factors driving the growth of the segment in the forecast period.
Acurx Pharmaceuticals, Cubist Pharmaceuticals, Endo Aesthetics, Avisa Pharma, and MGB Bio Pharma, among others, are anticipated to play a significant role in developing the market during the forecast period. Emerging entities are taking several initiatives that are likely to benefit the industry during the forecast period.
Key players in the global clostridium diagnostics market include Abbott Laboratories, F. Hoffmann-LA ROCHE AG, Siemens AG, Becton Dickinson and Company, and Beckman Coulter, INC.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 12.2% from 2022 to 2032 |
| Market Value in 2022 | US$ 2.5 Billion |
| Market Value in 2032 | US$ 7.8 Billion |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2021 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The global clostridium diagnostics market is expected to display a CAGR of 12.2% during the forecast period.
The clostridium diagnostics market is anticipated to secure a market value worth US$ 7.8 Billion by 2032.
Abbott Laboratories, F. Hoffmann-LA ROCHE AG, and Siemens AG are some of the eminent players in the global clostridium diagnostics market
The U.S is projected to dominate the clostridium diagnostics market with a market value worth US$ 2.7 Billion by 2032.
Immunoassays technology segment is projected to dominate the clostridium diagnostics market with a CAGR of 11.7% from 2022-2032
The U.K Clostridium Diagnostics market is anticipated to secure US$ 330 Million by 2032
1. Executive Summary 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Clostridium Diagnostics 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032 6.1. Historical Market Analysis, 2015-2021 6.2. Current and Future Market Projections, 2022-2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Technology 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032 8.3.1. IMMUNOASSAYS 8.3.2. MOLECULAR DIAGNOSTICS 8.4. Market Attractiveness Analysis By Technology 9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032 9.3.1. CLOSTRIDIUM DIFFICILE 9.3.2. CLOSTRIDIUM PERFRINGENS 9.3.3. CLOSTRIDIUM BOTULINUM 9.3.4. CLOSTRIDIUM TETANI 9.3.5. CLOSTRIDIUM SORDELLII 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2015-2021 and Forecast 2022-2032, By End-user 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By End-user, 2015-2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-user, 2022-2032 10.3.1. HOSPITALS 10.3.2. GOVERNMENT DIAGNOSTIC LABORATORIES 10.3.3. INDEPENDENT LABORATORIES 10.4. Market Attractiveness Analysis By End-user 11. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021 11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. Asia Pacific 11.3.5. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2015-2021 and Forecast 2022-2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 12.4.1. By Country 12.4.1.1. U.S. 12.4.1.2. Canada 12.4.1.3. Rest of North America 12.4.2. By Technology 12.4.3. By End-user 12.4.4. By Product 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Technology 12.5.3. By End-user 12.5.4. By Product 13. Latin America Market Analysis 2015-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Rest of Latin America 13.4.2. By Technology 13.4.3. By End-user 13.4.4. By Product 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Technology 13.5.3. By End-user 13.5.4. By Product 14. Europe Market Analysis 2015-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. France 14.4.1.3. U.K. 14.4.1.4. Italy 14.4.1.5. Benelux 14.4.1.6. Nordic Countries 14.4.1.7. Rest of Europe 14.4.2. By Technology 14.4.3. By End-user 14.4.4. By Product 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Technology 14.5.3. By End-user 14.5.4. By Product 15. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 15.4.1. By Country 15.4.1.1. China 15.4.1.2. Japan 15.4.1.3. South Korea 15.4.1.4. Rest of Asia Pacific 15.4.2. By Technology 15.4.3. By End-user 15.4.4. By Product 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Technology 15.5.3. By End-user 15.5.4. By Product 16. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 16.4.1. By Country 16.4.1.1. GCC Countries 16.4.1.2. South Africa 16.4.1.3. Turkey 16.4.1.4. Rest of Middle East and Africa 16.4.2. By Technology 16.4.3. By End-user 16.4.4. By Product 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Technology 16.5.3. By End-user 16.5.4. By Product 17. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032 17.1. Introduction 17.1.1. Market Value Proportion Analysis, By Key Countries 17.1.2. Global Vs. Country Growth Comparison 17.2. US Market Analysis 17.2.1. Value Proportion Analysis by Market Taxonomy 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.2.2.1. By Technology 17.2.2.2. By End-user 17.2.2.3. By Product 17.3. Canada Market Analysis 17.3.1. Value Proportion Analysis by Market Taxonomy 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.3.2.1. By Technology 17.3.2.2. By End-user 17.3.2.3. By Product 17.4. Mexico Market Analysis 17.4.1. Value Proportion Analysis by Market Taxonomy 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.4.2.1. By Technology 17.4.2.2. By End-user 17.4.2.3. By Product 17.5. Brazil Market Analysis 17.5.1. Value Proportion Analysis by Market Taxonomy 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.5.2.1. By Technology 17.5.2.2. By End-user 17.5.2.3. By Product 17.6. Germany Market Analysis 17.6.1. Value Proportion Analysis by Market Taxonomy 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.6.2.1. By Technology 17.6.2.2. By End-user 17.6.2.3. By Product 17.7. France Market Analysis 17.7.1. Value Proportion Analysis by Market Taxonomy 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.7.2.1. By Technology 17.7.2.2. By End-user 17.7.2.3. By Product 17.8. Italy Market Analysis 17.8.1. Value Proportion Analysis by Market Taxonomy 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.8.2.1. By Technology 17.8.2.2. By End-user 17.8.2.3. By Product 17.9. BENELUX Market Analysis 17.9.1. Value Proportion Analysis by Market Taxonomy 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.9.2.1. By Technology 17.9.2.2. By End-user 17.9.2.3. By Product 17.10. UK Market Analysis 17.10.1. Value Proportion Analysis by Market Taxonomy 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.10.2.1. By Technology 17.10.2.2. By End-user 17.10.2.3. By Product 17.11. Nordic Countries Market Analysis 17.11.1. Value Proportion Analysis by Market Taxonomy 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.11.2.1. By Technology 17.11.2.2. By End-user 17.11.2.3. By Product 17.12. China Market Analysis 17.12.1. Value Proportion Analysis by Market Taxonomy 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.12.2.1. By Technology 17.12.2.2. By End-user 17.12.2.3. By Product 17.13. Japan Market Analysis 17.13.1. Value Proportion Analysis by Market Taxonomy 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.13.2.1. By Technology 17.13.2.2. By End-user 17.13.2.3. By Product 17.14. South Korea Market Analysis 17.14.1. Value Proportion Analysis by Market Taxonomy 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.14.2.1. By Technology 17.14.2.2. By End-user 17.14.2.3. By Product 17.15. GCC Countries Market Analysis 17.15.1. Value Proportion Analysis by Market Taxonomy 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.15.2.1. By Technology 17.15.2.2. By End-user 17.15.2.3. By Product 17.16. South Africa Market Analysis 17.16.1. Value Proportion Analysis by Market Taxonomy 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.16.2.1. By Technology 17.16.2.2. By End-user 17.16.2.3. By Product 17.17. Turkey Market Analysis 17.17.1. Value Proportion Analysis by Market Taxonomy 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032 17.17.2.1. By Technology 17.17.2.2. By End-user 17.17.2.3. By Product 17.17.3. Competition Landscape and Player Concentration in the Country 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 18.4. Market Presence Analysis 18.4.1. By Regional footprint of Players 18.4.2. Product footprint by Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. ABBOTT LABORATORIES 19.3.1.1. Overview 19.3.1.2. Product Portfolio 19.3.1.3. Sales Footprint 19.3.1.4. Strategy Overview 19.3.2. F. HOFFMANN-LA ROCHE AG 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Sales Footprint 19.3.2.4. Strategy Overview 19.3.3. SIEMENS AG 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Sales Footprint 19.3.3.4. Strategy Overview 19.3.4. BECTON, DICKINSON AND COMPANY 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Sales Footprint 19.3.4.4. Strategy Overview 19.3.5. BECKMAN COULTER, INC. 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Sales Footprint 19.3.5.4. Strategy Overview 19.3.6. SYSMEX INDIA PVT. LTD. 19.3.6.1. Overview 19.3.6.2. Product Portfolio 19.3.6.3. Sales Footprint 19.3.6.4. Strategy Overview 19.3.7. THERMO FISHER SCIENTIFIC INC. 19.3.7.1. Overview 19.3.7.2. Product Portfolio 19.3.7.3. Sales Footprint 19.3.7.4. Strategy Overview 19.3.8. FUJIREBIO US, INC. 19.3.8.1. Overview 19.3.8.2. Product Portfolio 19.3.8.3. Sales Footprint 19.3.8.4. Strategy Overview 19.3.9. BIOMÉRIEUX SA 19.3.9.1. Overview 19.3.9.2. Product Portfolio 19.3.9.3. Sales Footprint 19.3.9.4. Strategy Overview 19.3.10. DIAZYME LABORATORIES, INC. 19.3.10.1. Overview 19.3.10.2. Product Portfolio 19.3.10.3. Sales Footprint 19.3.10.4. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Clostridium Diagnostics Market
